It's good to see inc that they have finally caught up to your research regarding southern flank and it's potential.I'm sure they already new but nice to see it publicly stated instead of leaving the pr work up to you
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%